Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biomedical Diagnostics CE marks test to tailor autoimmune disease treatment

This article was originally published in Clinica

Executive Summary

Autoimmune disease specialist Biomedical Diagnostics (Marne la Vallée, France) has CE marked its Lisa Tracker Premium test kit for sale in Europe. The diagnostic is designed to improve the management of autoimmune diseases such as rheumatoid arthritis and Crohn’s disease. It simultaneously measures levels of the cytokine tumour necrosis factor (TNF)-α, anti-TNF drugs, and neutralising anti-drug antibodies (ADAs). TNF-α is involved in inflammation and is often elevated in autoimmune disorders. TNF inhibitors such as infliximab and etanercept are less effective in patients who develop ADAs, who often experience a relapse of disease. Measuring these three parameters therefore helps physicians predict a patient’s response to these medications and tailor treatment accordingly.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094640

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel